cefixime has been researched along with Campylobacter Infection in 2 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Debelo, M | 1 |
Mohammed, N | 1 |
Tiruneh, A | 1 |
Tolosa, T | 1 |
Pascual, A | 1 |
Martínez-Martínez, L | 1 |
García-Gestoso, ML | 1 |
Romero, J | 1 |
2 other studies available for cefixime and Campylobacter Infection
Article | Year |
---|---|
Isolation, identification and antibiotic resistance profile of thermophilic Campylobacter species from Bovine, Knives and personnel at Jimma Town Abattoir, Ethiopia.
Topics: Abattoirs; Agar; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections | 2022 |
Urinary tract infection caused by quinolone-resistant Campylobacter coli.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Cefixime; Cefotaxime; Female; H | 1994 |